Organization | Grupo de Investigación Clínica en Oncología Radioterapia

Grupo de Investigación Clínica en Oncología Radioterapia Report issue

Academic/Hospital Phase 2 Phase 3

Founded: Madrid Spain (1998)

Organization Overview

First Clinical Trial

2005

NCT02175212

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Grupo de Investigación Clínica en Oncología Radioterapia

Active Ingredients

Drugs in Phase 3 Trials (4)

bicalutamide (casodex) (1 trial)

cisplatin (platinol) (1 trial)

erlotinib (tarceva) (1 trial)

goserelin (zoladex) (1 trial)

Drugs in Phase 2 Trials (2)

fluoromisonidazole (1 trial)

temozolomide (temodar) (1 trial)

Drugs in Other Trials (8)

azithromycin (zithromax) (1 trial)

chondroitin (1 trial)

enoxaparin (lovenox) (1 trial)

hyaluronic acid (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

lopinavir (Kaletra) (1 trial)

ritonavir (Norvir) (1 trial)

tocilizumab (actemra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Adenocarcinoma (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Glioma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 5
# of Trial APIs: 14